Evogene Ltd. — Form D
Evogene Ltd. of REHOVOT, L3, a company, filed a Form D exempt-offering notice with the SEC on 2026-02-19. The offering totals $3.4M, of which $3.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2026-02-19
- Form: D
- Accession: 0001178913-26-000573
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.4M
- Amount sold: $3.4M
- Investors: 1
- Date of first sale: 2026-02-11
- Revenue range: Decline to Disclose
- SEC file number: 021-574080
Issuer
- Name: Evogene Ltd.
- CIK: 0001574565
- Entity type: Corporation
- Jurisdiction: ISRAEL
- Address: 13 GAD FEINSTEIN STREET, REHOVOT, L3, 7638517
- Phone: 97289311900
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Ofer Haviv | Director | Rehovot, L3 |
| Leon Yehuda Recanati | Director | Rehovot, L3 |
| Gabi Tarcic | Executive Officer | Rehovot, L3 |
| Ilia Zhidkov | Executive Officer | Rehovot, L3 |
| Sarit Firon | Director | Rehovot, L3 |
| Nir Nimrodi | Director | Rehovot, L3 |
| Yaron Eldad | Executive Officer | Rehovot, L3 |
| Eyal Ronen | Executive Officer | Rehovot, L3 |
| Dan Falk | Director | Rehovot, L3 |
| Sassi Masliah | Executive Officer | Rehovot, L3 |
| Oded Y Shoseyov | Director | Rehovot, L3 |
| Adrian Percy | Director | Rehovot, L3 |
| Ofer Haviv | Executive Officer | Rehovot, L3 |
| Leon Y Recanati | Director | Rehovot, L3 |
| Mark Kapel | Executive Officer | Rehovot, L3 |
Other filings by this issuer (1)
More